ACER2 and hepatocellular carcinoma: ACER2 was reported to be overexpressed in hepatocellular carcinoma (HCC) tissue and to induce growth, invasion, and migration in HCC cell lines via sphingomyelin phosphodiesterase acid-like 3B (SMPDL3B) [52].